Skip to main

Living Donation and Pregnancy-Related Complications: State of the Evidence and Call To Action for Improved Risk Assessment

Living Donation and Pregnancy-Related Complications: State of the Evidence and Call To Action for Improved Risk Assessment

AST's WHCOP and LDCOP welcome Drs. Rossi, Lentine, Khoury, and Caza to discuss findings from the WHCOP Controversies Conference on reproductive health, contraception, and pregnancy after transplantation and living donation.

  • 2:00 PM - 3:00 PM EDT
  • Virtual

"Living Donation and Pregnancy-Related Complications: State of the Evidence and Call To Action for Improved Risk Assessment" (Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1659-1670. doi: 10.2215/CJN.0000000593. Epub 2024 Sep 20.)

This article features work from an AST Controversies Conference:

In February 2023, the American Society of Transplantation Women's Health Community of Practice (WCHOP) held a virtual Controversies Conference on reproductive health, contraception, and pregnancy after transplantation and living donation. This AST Journal Club features work from that conference, and discusses how the creation of a registry of donor candidates may help answer many [questions on this topic] and, in turn, educate prospective donors so that they can make an informed choice. Read more.

Speakers: 

  • Ana Rossi, MD, MPH, FAST • Piedmont Transplant Institute, Atlanta, GA
  • Krista Lentine, MD, PhD, FAST • Saint Louis University School of Medicine, St. Louis, MO

Moderators:

  • Nadeen Khoury, MD, FAST • Henry Ford Health, Detroit, MI
  • Tiffany Caza, MD, PhD • Arkana Laboratories, Little Rock, AR

 


This AST Journal Club Series webinar is hosted by the AST Women's Health Community of Practice (WHCOP) and Living Donor Community of Practice (LDCOP).

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi